MOH-WHO Highlights Biologicals/ Biosimilar Regulations

MOH-WHO Highlights Biologicals/ Biosimilar Regulations

MOH-WHO Highlights Biologicals/ Biosimilar Regulations

12/2/2019

The Directorate-General of Pharmaceutical Affairs & Drug Control (DGPADC) in collaboration with the World Health Organization (WHO) Office organized today (Tuesday) a workshop on Regulations of Biologicals/ Biosimilar at Levatio Hotel Muscat.

The workshop was attended by Dr. Mohammed bin Hamdan Al-Rubai'i, DGPADC Director General along with participation of Dr. Elwyn Griffiths, WHO Consultant.

The workshop gathered around (30) participants including the DGPADC specialists, members of Supreme Committee of Medication, members of Technical Committee for Registration of Pharmaceutical Companies and their products along with number of concerned authorities.

  Click Here for More Details



Comments